|
| Noura S Abul-Husn | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Noura S Abul-Husn | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Claudia Schurmann | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Shane McCarthy | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Shane McCarthy | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Colm O'Dushlaine | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Alexander Lopez | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| John Penn | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Uyenlinh L Mirshahi | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| David J Carey | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| David J Carey | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Christopher D Still | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Brian M Feldman | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Aeron M Small | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Scott M Damrauer | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Scott M Damrauer | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Daniel J Rader | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Andrew J Murphy | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Ingrid B Borecki | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Alan R Shuldiner | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Alan R Shuldiner | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Jeffrey G Reid | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Jeffrey G Reid | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| John D Overton | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| John D Overton | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| George D Yancopoulos | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Omri Gottesman | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Omri Gottesman | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Tanya M Teslovich | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Aris Baras | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Tooraj Mirshahi | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Jesper Gromada | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |
| Frederick E Dewey | F.E.D.) and Regeneron Pharmaceuticals (X. Cheng, NY the University of Texas Southwestern Medical Center at Dallas, and Perelman School of Medicine, University of Pennsylvania |